Engrafting costimulator molecules onto tumor cell surfaces with chelator lipids: A potentially convenient approach in cancer vaccine development

Journal of Immunology

Volumn 164, Issue 5, 2000, Pages 2433-2443

  Van Broekhoven, Christina L ^a   Parish, Christopher R ^b   Vassiliou, Gerard ^c   Altin, Joseph G ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b Biology and Environment   (Australia)

^c UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CANCER VACCINE; CD40 ANTIGEN; CHELATING AGENT; IMMUNOSTIMULATING AGENT; NITRILOTRIACETIC ACID DITETRADECYLAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL PROTECTION; CONTROLLED STUDY; DRUG BINDING; DRUG DESIGN; DRUG UPTAKE; FEMALE; LYMPHOCYTE PROLIFERATION; MALE; MEMBRANE STRUCTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TUMOR CELL; VACCINE PRODUCTION;

EID: 0034162536     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.5.2433     Document Type: Article

References (30)

1. Chen, L., P. McGowan, S. Ashe, J. Johnston, Y. Li, I. Hellström, and K. E. Hellström. 1994. Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. Exp. Med. 179:523.
2. Yang, G., H. E. Hellstrom, I. Hellstrom, and L. Chen. 1995. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules. J. Immunol. 154:2794.
3. + T lymphocytes. J. Immunol. 152:1523.
4. Cavallo, F., A. Martin-Fontecha, M. Bellone, S. Heltai, E. Gatti, P. Tornaghi, M. Freschi, G. Forni, P. Dellabona, and G. Casorati. 1995. Co-expression of B7-1 and ICAM-1 or tumors is required for rejection and the establishment of a memory response. Eur. J. Immunol. 25:1154.
5. Chen, L. 1997. Manipulation of T cell response to tumors by targeting on co-stimulatory pathway. Leukemia 11:567.
6. McHugh, R. S., S. N. Ahmed, Y.-C. Wang, K. W. Sell, and P. Selvaraj. 1995. Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80). Proc. Natl. Acad. Sci. USA 92:8059.
7. Brunschwig, E. B., E. Levine, U. Trefzer, and M. L. Tykocinski, 1995. Glycosylphosphatidylinositol-modified murine B7-1 and B7-2 retain costimulator function. J. Immunol. 155:5498.
8. Yu, X., R. Abe, and R. J. Hobbes. 1998. The role of B7-CD28 co-stimulation in tumor rejection. Int. Immunol. 10:791.
9. Arnold, F. H. 1991. Metal-affinity separations: a new dimension in protein processing. Bio/Technology 9:151.
10. Dorn, I. T., K. Pawlitschko, S. C. Pettinger, and R. Tampe. 1998. Orientation and two dimensional organization of proteins at chelator lipid interfaces. Biol. Chem. 379:1151.
11. Wrobel, I., and D. Collins. 1995. Fusion of cationic liposomes with mammalian cells occurs after endocytosis. Biochim. Biophys. Acta 1235:296.
12. Farhood, H., N. Serbina, and L. Juang. 1995. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim. Biophys. Acta 1235:289.
13. Schmitt, L., C. Dietrich, and R. Tampé. 1994. Synthesis and characterization of chelator-lipids for reversible immobilization of engineered proteins at self-assembled lipid interfaces. J. Am. Chem. Soc. 116:8485.
14. Altin, J. G., E. B. Pagler, and C. R. Parish. 1994. Evidence for cell surface association of CD2 and LFA-1 (CD11a/CD18) on T lymphocytes. Eur. J. Immunol. 24:450.
15. Parish, C. R., S. M. Kirov, N. Bowern, and R. V. Blanden. 1974. A one-step procedure for separating mouse T and B lymphocytes. Ear. J. Immunol. 4:808.
16. Greenfield, E. A., E. Howard, T. Paradis, K. Nguyen, F. Benazzo, P. McLean, P. Hollsberg, G. Davis, D. A. Hafler, A. H. Sharpe, et al. 1997. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA-4 binding. J. Immunol. 158:2025.
17. Chen, L., P. McGowan, S. Ashe, J. Johnston, I. Hellstrom, and K. E. Hellstrom. 1994. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum. Cancer Res. 54:5420.
18. Rennert, P., K. Fulong, C. Hellis, E. Greenfield, G. J. Freeman, Y. Ueda, B. Levin, C. H. June, and G. S. Gay. 1997. The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion. Int. Immunol. 9:805.
19. Li, L. H., and S. W. Hui. 1997. The effect of lipid molecular packing stress on cationic liposome-induced rabbit erythrocyte fusion. Biochim. Biophys. Acta 1323:105.
20. Lehtonen, J. Y. A., and P. K. J. Kinnunen. 1994. Changes in the lipid dynamics of liposomal membranes induced by poly(ethylene glycol): free volume alterations revealed by inter- and intra-molecular excimer-forming phospholipid analogs. Biophys. J. 66:1981.
21. Ahkong, Q. F., and J. A. Lucy. 1986. Osmotic forces in artificially induced cell fusion. Biochem. Biophys. Acta 858:206.
22. Greenberg, P. D. 1991. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv. Immunol. 49:281.
23. Melief, C. J. M. 1992. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer. Res. 58:143.
24. Yang, G., M. T. Mizuno, K. E. Hellström, and L. Chen. 1997. B7-negative versus B7-positive P815 tumor-differential requirements for priming of an antitumor immune response in lymph nodes. J. Immunol. 158:851.
25. van Gool, S. W., P. Vandenberghe, M. de Boer, and J. L. Ceuppens. 1996. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model. Immunol. Rev. 153:47.
26. Hellstrom, K. E., I. Hellstrom, and L. Chen. 1995. Can co-stimulated tumor immunity be therapeutically efficacious? Immunol Rev. 145:123.
27. Elliot, B. E., D. A. Carlow, A.-M. Rodricks, and A. Wade. 1989. Perspectives on the role of MHC antigens in normal and malignant cell development. Adv. Cancer. Res. 53:181.
28. Ada, G. L. 1993. Vaccines. In Fundamental Immunology. W. E. Paul, ed. Raven, New York, pp. 1309-1352.
29. Vassiliou, G., K. Jakobsen, and C. R. Parish. 1998. Detection of low affinity adhesion ligands by linking recombinant cell adhesion molecules in uniform orientation to a fluorescently labeled dextran molecule by means of hexahistidine tagging: the case of multimeric CD40. J. Immunol. Methods 215:9.
30. Maxwell, J. R., J. D. Campbell, C. H. Kim, and A. T. Vella. 1999. CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion. J. Immunol. 162:2024.